Revenue grew 9.24% to CNY 5.61 billion and net profit rose 0.83% to CNY 910 million in 2023, with strong performance in life science, industrial, and consumer goods testing, continued strategic investments, and enhanced internationalization and digital transformation.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.